Last reviewed · How we verify
Alcohol withdrawal syndrome
Approved treatments
- Valium · Generic (originally Roche)
- Chlordiazepoxide Hydrochloride · Bausch Health
- Tranxene · Ajenat Pharms
- Emineurina
Emineurina works by enhancing the activity of the neurotransmitter GABA, which helps to calm excessive brain activity.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Alcohol withdrawal syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Alcohol withdrawal syndrome treatment landscape brief
- Alcohol withdrawal syndrome treatment updates RSS
Frequently asked questions about Alcohol withdrawal syndrome
What drugs treat Alcohol withdrawal syndrome?
Tracked treatments include Valium, Chlordiazepoxide Hydrochloride, Tranxene, Emineurina.
What is the treatment for Alcohol withdrawal syndrome?
Standard treatment for Alcohol withdrawal syndrome includes Valium, Chlordiazepoxide Hydrochloride, Tranxene, Emineurina. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Alcohol withdrawal syndrome patent cliff · Alcohol withdrawal syndrome CI report
- Treatment: Valium · Generic (originally Roche)
- Treatment: Chlordiazepoxide Hydrochloride · Bausch Health
- Treatment: Tranxene · Ajenat Pharms
- Treatment: Emineurina
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing